生物技術市場規模、佔有率及成長分析（按產品類型、技術、應用、最終用戶和地區）－2025-2032 年產業預測

預計 2023 年生物技術市場規模將達到 2.12 兆美元，並從 2024 年的 2.39 兆美元成長到 2032 年的 6.26 兆美元，預測期間（2025-2032 年）的複合年成長率為 12.79%。

生技產業是一個高度全球化的產業，各國的經濟成長各不相同。日益嚴重的健康問題，尤其是B型肝炎、糖尿病和癌症等慢性疾病，預計將推動對生物技術解決方案的需求。美國、中國和印度等主要國家的人口正在成長，這可能會增加對小麥、米和甘蔗等農產品的需求。同時，科學家們積極致力於智慧農業系統的研究和開發，以緩解水資源短缺、低產量和病蟲害威脅等挑戰。與政府機構和獨立公司的合作正在增加研發資金並刺激生物技術創新。因此，該領域的公司將迎來重大機遇，尤其是那些專注於開發有效治療方法的公司。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

生物技術市場規模（依產品類型）

• 市場概覽
• 裝置
• 試劑
• 服務
• 軟體

生物技術市場規模（依技術分類）

• 市場概覽
• 奈米生物技術
• PCR技術
• DNA定序
• 層析法
• 組織工程與再生
• 基於細胞的檢測
• 發酵
• 其他

生物技術市場規模（按應用）

• 市場概覽
• 生物製藥
• 生物產業
• 生物服務
• 生物資訊學
• 生物農業

生物技術市場規模（按最終用戶分類）

• 市場概覽
• 製藥和生物技術公司
• 合約研究組織
• 學術研究所
• 其他

生物技術市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Amgen Inc.（USA）
• Gilead Sciences, Inc.（USA）
• Genentech（Roche）（Switzerland）
• Biogen Inc.（USA）
• Regeneron Pharmaceuticals, Inc.（USA）
• Moderna, Inc.（USA）
• Illumina, Inc.（USA）
• Vertex Pharmaceuticals（USA）
• AbbVie Inc.（USA）
• Eli Lilly and Company（USA）
• Sanofi SA（France）
• Novozymes（Denmark）
• CSL Limited（Australia）
• Celgene Corporation（USA）
• Bristol-Myers Squibb Company（USA）
• Novo Nordisk（Denmark）
• AstraZeneca PLC（UK/Sweden）
• Stryker Corporation（USA）
• Merck & Co., Inc.（USA）
• Johnson & Johnson（USA）

結論和建議

Biotechnology Market size was valued at USD 2.12 trillion in 2023 and is poised to grow from USD 2.39 trillion in 2024 to USD 6.26 trillion by 2032, growing at a CAGR of 12.79% during the forecast period (2025-2032).

The biotech industry is a highly globalized sector experiencing diverse economic growth across nations. Rising health issues, particularly hepatitis B and chronic diseases like diabetes and cancer, are anticipated to drive demand for biotech solutions. The increasing populations in major countries such as the US, China, and India will also heighten the need for agricultural products, including wheat, rice, and sugarcane. Concurrently, scientists are actively engaged in R&D to mitigate challenges such as water scarcity, low crop yield, and pest threats, focusing on smart agricultural systems. Collaborative efforts with both governmental and independent entities are boosting funding for research and development, fostering innovations in biotechnology. Consequently, companies in this field are poised for significant opportunities, particularly those dedicated to developing effective treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biotechnology Market Segments Analysis

Global Biotechnology Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Instruments, Reagents, Services and Software. Based on Technology, the market is segmented into Nano Biotechnology, PCR Technology,DNA sequencing, Chromatography, Tissue Engineering and Regeneration, Cell-Based Assays, Fermentation and Others. Based on Application, the market is segmented into Bio-pharmacy, Bio-industrial, Bio-services, Bioinformatics and Bio-agriculture. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biotechnology Market

The global biotechnology market is being significantly driven by the rising incidence of chronic diseases, including cancer and diabetes. As the prevalence of these health issues escalates worldwide, there is a correspondingly growing demand for effective treatments. This urgent need for innovative therapeutic solutions is propelling the expansion of the biotechnology sector on a global scale. The increasing focus on research and development in biotechnology to address these pressing health concerns is further enhancing market growth. As a result, the biotechnology industry is poised for continuous advancement and investment, driven by the imperative to combat chronic illnesses effectively.

Restraints in the Biotechnology Market

The biotechnology sector is heavily reliant on innovation, and when one company secures a patent by being the first to develop a new technology, it can create significant delays for competing firms seeking to bring similar products to market. This situation arises because competitors are unable to use patented methods without facing legal challenges, leading to potential conflicts over intellectual property rights. Such patent-related issues and overlaps can act as considerable barriers to market growth, as they restrict the ability of other companies to leverage similar technologies and diminish their competitive edge in bringing innovative solutions to consumers.

Market Trends of the Biotechnology Market

The biotechnology market is witnessing a significant trend towards synthetic biology, a rapidly growing segment poised to revolutionize various industries including pharmaceuticals, agriculture, and biofuels. This innovative approach enables companies to design and engineer biological systems for diverse applications, enhancing efficiency and sustainability. As the demand for eco-friendly solutions escalates, biotechnology firms are increasingly investing in synthetic biology to develop novel products and processes that address global challenges such as climate change and health crises. By leveraging advances in genetic engineering and computational biology, these companies are not only maximizing revenue opportunities but also positioning themselves as leaders in the future of biotechnological advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Biotechnology Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents
• Services
• Software

Global Biotechnology Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Nano Biotechnology
• PCR Technology
• DNA Sequencing
• Chromatography
• Tissue Engineering and Regeneration
• Cell-Based Assays
• Fermentation
• Others

Global Biotechnology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Bio-pharmacy
• Bio-industrial
• Bio-services
• Bioinformatics
• Bio-agriculture

Global Biotechnology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutes
• Others

Global Biotechnology Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Amgen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (Roche) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertex Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (UK/Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations